Sign in
4

Changes in Ownership

CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001628280-25-013527

Options or other derivatives

  • Vice Pres Organizational Dev acquired 3,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Anthony Todd M. Vice Pres Organizational Dev 2025-03-17 Grant or award · Options (right to buy) +3,000 $5.17 $15,510 18,000 D
Loading xslF345X05/wk-form4_1742332195.xml…